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Abstract
There is scarce information regarding hospital-acquired infections (HAIs) among children in resource-constrained settings. This study
aims to measure prevalence of HAIs in Vietnamese pediatric hospitals.
Monthly point prevalence surveys (PPSs) in 6 pediatric intensive care units (ICUs) in 3 referral hospitals during 1 year.
A total of 1363 cases (1143 children) were surveyed, 59.9%male, average age 11months. Admission sources were: other hospital
49.3%, current hospital 36.5%, and community 15.3%. Reasons for admission were: infectious disease (66%), noninfectious
(20.8%), and surgery/trauma (11.3%). Intubation rate was 47.8%, central venous catheter 29.4%, peripheral venous catheter 86.2%,
urinary catheter 14.6%, and hemodialysis/ﬁltration 1.7%. HAI was diagnosed in 33.1% of the cases: pneumonia (52.2%), septicemia
(26.4%), surgical site infection (2%), and necrotizing enterocolitis (2%). Signiﬁcant risk factors for HAI included age under 7 months,
intubation and infection at admission. Microbiological ﬁndings were reported in 212 cases (43%) with 276 isolates: 50 Klebsiella
pneumoniae, 46 Pseudomonas aeruginosa, and 39 Acinetobacter baumannii, with carbapenem resistance detected in 55%, 71%,
and 65%, respectively. Staphylococcus aureus was cultured in 18 cases, with 81% methicillin-resistant Staphylococcus aureus.
Most children (87.6%) received antibiotics, with an average of 1.6 antibiotics per case. Colistin was administered to 96 patients, 93%
with HAI and 49% with culture conﬁrmed carbapenem resistance.
The high prevalence of HAI with carbapenem resistant gram-negative strains and common treatment with broad-spectrum
antibiotics and colistin suggests that interventions are needed to prevent HAI and to optimize antibiotic use.
Abbreviations: CRF = case record form, ECDC = European Center for Disease Prevention and Control, HAI = hospital-acquired
infection, ICU = intensive care unit, LMIC = low and middle income countries, PPS = point prevalence survey.
Keywords: hospital-acquired infections, ICU, pediatric, Vietnam
1. Introduction
Estimates of the burden of hospital-acquired infections (HAI),
particularly among children, in low and middle income countries
(LMIC) are not well known and most LMIC do not have any
published data on HAI prevalence.[1] A recent European
multicenter study on HAI in pediatric wards showed an HAI
prevalence ranging from 2.5% in general pediatric ward to
23.6% in pediatric intensive care unit (ICU) setting.[2] High rates
of HAI have also been reported in Neonatal Intensive Care
Units[3] with an HAI prevalence 3 to 20 times higher in resource-
limited settings compared to high income settings.[4]
Vietnam is a low middle income country with a rapidly
expanding public and private healthcare sector.[5] Gross national
income per capita per year is 3620$, total public expenditure on
health per capita is around 234$ per year, about 80% of health
expenditure is out of pocket payment. In the community,
antibiotics are commonly used and mostly obtained through
private pharmacies and clinics;[5] this in combination with high
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incidence of infectious diseases makes Vietnam a hotspot for
antimicrobial resistance with rates among the highest recorded in
Asia.[6] The health care sector is overstrained with a relatively low
number of health staff per capita, 7 physicians per 10,000
population, and overcrowding with hospital bed occupancy up to
170%.[5]
Currently, there is no national surveillance system for HAI in
Vietnam and there is limited data about HAI in ICUs. The few
studies performed on HAI are small and only include a few ICUs.
There is 1 published Vietnamese point prevalence survey (PPS) in
36 hospitals that showed high HAI prevalence in ICUs.[7]
Additionally, antibiotic resistance is high with up to 70% of
Enterobacteriaceae resistant to 3rd-generation cephalosporins
and more than 40% of Acinetobacter species resistant to
carbapenems.[5,7] Increasing prevalence of HAI caused by
carbapenem resistant gram-negative bacteria such as Enter-
obacteriaceae is likely to cause an unprecedented public health
crisis in LMIC settings where much of the advances in medical
care may be jeopardized.[8]
We performed a 1-year once per month point prevalence study
using the European Center for Disease Prevention and Control
(ECDC) protocol to estimate HAI on pediatric ICUs. The results
can be used to develop contextualized intervention strategies in
Vietnam and other countries in the Asian region, where more
than 50% of the world population lives.
2. Methods
2.1. Study design and study sites
The prevalence of HAIs, antibiotic use, and antibiotic resistance
were assessed using PPS methodology developed by the ECDC.[9]
The PPS protocol was contextualized for the local situation,
without changing the deﬁnitions for HAI.[10,11] The PPS survey
was conducted on a single day and repeated once per month from
October 2012 to September 2013 at 2 specialized tertiary referral
pediatric hospitals serving northern and southern provinces, the
National Hospital for Paediatrics in Hanoi and Children
Hospital 1 in Ho Chi Minh City and one specialized infectious
diseases hospital serving Southern provinces, Hospital of
Tropical Disease in Ho Chi Minh City. The hospitals are called
Hospital 1, 2, and 3 (H1, H2, and H3) throughout the article due
to integrity for the speciﬁc hospitals. Ethical approval was
obtained from the ethical committee of the National Hospital for
Tropical Diseases (code 27/HDDD-NHTD date 06/11/2012),
and permission was obtained from the Vietnamese Ministry of
Health (code 4921/QD-BYT date 11/12/2012). The need for
informed consent for the PPS was waived.
2.2. Data collection
Data on hospital and ICU infrastructure and resources, and
patient data were collected using a standardized case record form
(CRF; see Supplementary information, http://links.lww.com/
MD/B128). A training course on deﬁnition of HAI, how to ﬁll
in the CRF and entering data into the HELICS-Win database,[9]
was provided for participating staff. A study initiation visit was
performed in each ICU, which included hands-on training on site.
Data were obtained using the CRF once amonth from all patients
admitted to the ICU before 8 ≻am on the day of the survey. The
data were uploaded monthly to a central database where data
were checked for missing or inaccurate data. In case of
inconsistencies or inaccuracies, queries were sent to the hospitals.
Repeat visits were done by study investigators to assist in
reconciliation of data and on-going training.
The following patient data were gathered: age and gender, date
of admission to hospital, and date of admission to ICU. Basic
clinical information was collected, including primary reason for
ICU admission (communicable vs noncommunicable disease),
comorbidities, surgical interventions, or invasive procedures. It
was also noted whether any family member had actively assisted
in patient care during the preceding 24hours, which is common
due to lack of staff and resources in the Vietnamese hospital
setting. Antibiotic use was deﬁned as: having received the 1st dose
of antibiotics at time of survey, admitted with on-going antibiotic
treatment, or antibiotic prophylaxis within the last 24hours. If
the patient had received antimicrobials the type of antibiotic,
indication for antibiotic use, route of administration, diagnosis of
infection, and reason given in patient notes (if the antibiotic
treatment was motivated from clinical or microbiological
perspective or not).
HAI was deﬁned using ECDC criteria and is brieﬂy described
here at least one of the following criteria: infection beginning
≥48hours after admission to any hospital, surgical site infection
30 days following surgery, patient discharged from acute care
hospital 48hours, infection beginning 3 days following
invasive procedure, or patient on treatment for HAI meeting
any of above requirements when treatment was initiated. If a
patient had a suffered from HAI the diagnosis and source of
infection was documented, along with whether relevant device for
administering antibioticswas in situ before onset or not, andorigin
of infection (current orother hospital). If available,microbiological
data including type of culture (blood, sputum, urine, and wound),
cultured organism, and antibiotic resistance were collected.
2.3. Data analysis
Statistical analysis included descriptive statistic analysis for the
calculation of percentage, frequency, mean and median values,
and 95% conﬁdence interval (95%CI). Risk factors for HAI were
analyzed with univariate analysis using Chi-square, odds ratio
(OR), and 95%CI; and all variables signiﬁcant in the univariate
analysis at a P-value <0.10 were included in a multivariate
regression analysis using binary logistic regression. The analysis
was based on cases (not unique patients). The IBM SPSS Statistics
software (version 22 IBM, CA) was used for data analysis.
P-value <0.05 was considered signiﬁcant, using 2-sided for
general variables as sex and age, and 1-sided for variables
considered risk factors for HAI as invasive procedures.
3. Results
In total 1363 pediatric cases were included in the PPS
representing 1143 unique patients. The mean was 1.19 surveys
per patient, 118 patients (10.3%) were included in more than 1
survey, 82 patients in 2 surveys, and 36 in 3 or more surveys. The
majority of surveyed cases, 1010/1363 (74.1%), were collected at
H1 of which 409 (40.5%) were from neonatal ICU, 329 (32.6%)
from medical ICU, and 272 (26.9%) from the surgical ICU. The
other 2 hospitals included cases from medical pediatric ICUs. H2
had 191 cases (14%) and H3 had 162 cases (11.9%).
Boys were overrepresented: 812/1363 (59.6%). The mean age
was 11 months with a median of 3 months. The most common
reason for admission was an infectious disease (n=900; 66%),
followed by noncommunicable disease (n=283; 20.7%),
emergency surgery (n=96; 7%), elective surgery (n=58;
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4.3%), and trauma (n=5; <1%). The intubation rate was 659
(44.6%).
An HAI was diagnosed in 454/1363 child surveys (33.3%).
The prevalence of HAI varied between the hospitals and wards
from 14.8% to 50% (Table 1). At H1 the HAI prevalence varied
between wards from 30.1% in the surgical ICU to 36.7% in the
neonatal ICU. Of the 454 child surveys that fulﬁlled the criteria
for HAI, 45 (9.9%) were noted to have 2 HAIs and 6 children
(1.3%) had 3 HAIs.
Signiﬁcant risk factors (P<0.05) for HAI (Table 2) in
univariate (Chi-square) and multivariate analysis (binary logistic
regression) were: age 6 months and under (OR 2.06; 95%CI
1.59–2.65); source of the patient was the same hospital as the
surveyed ICU, hence not referred from another hospital (OR
1.46, 95%CI 1.16–1.84); that the reason for hospital admission
was infectious disease (OR 1.60, 95%CI 1.25–2.06); any
comorbidity (OR 2.5, 95%CI 1.35–4.64); and intubation (OR
1.99, 95%CI 1.59–2.51). Family involvement in patient care was
Table 2
Risk factors for HAI, uni- and multivariate analysis.
Risk factors
Cases
N (%)
Cases with
HAI N (%)
P-value
Chi-square
Odds ratio
95% CI
Binary logistic
regression
Gender Male 817 (59.9) 278 (34.0) 0.43 1.11 NA
Female 575 (42.2) 173 (30.1) 0.88–1.40
Missing 3
Age group <=6 months 906 (66.5) 348 (38.4) <0.000
∗∗
2.06 0.000
∗∗
>6 months 456 (33.5) 106 (23.2) 1.59–2.65
Missing 1
Comorbidity Yes 43 (3.2) 23 (53.5) 0.004
∗∗
2.5 0.017
∗
No 1295 (95.0) 420 (32.4) 1.35–4.64
Missing 26 11 (42.3)
Intubation Yes 652 (47.8) 269 (41.3) <0.000
∗∗
1.99 0.000
∗∗
No 710 (52.1) 185 (26.1) 1.59–2.51
Missing 1
Central catheter Yes 401 (29.4) 140 (34.9) 0.22 1.11 NA
No 961 (70.5) 314 (32.7) 0.87–1.42
Missing 1 0
Urinary catheter Yes 199 (14.6) 56 (28.1) 0.054 0.75 NA
No 1163 (85.3) 398 (34.2) 0.54–1.05
Missing 1 0
Hemodialysis Yes 23 (1.7) 8 (34.8) 0.52 1.07 NA
No 1339 (98.2) 446 (34.1) 0.45–2.54
Missing 1 0
Peripheral catheter Yes 1175 (86.2) 401 (34.1) 0.070 1.31 NA
No 186 (13.6) 53 (28.5) 0.93–1.84
Missing 2 0
Family involved in patient care Yes 61 (4.5) 10 (16.4) <0.009
∗
0.38 0.037
∗
No 1300 (95.4) 444 (34.1) 0.19–0.75
Missing 2
Source of patients Current hospital 492 (36.1) 190 (38.6) <0.004
∗∗
1.46 0.010
∗
Community, Other hospital 852 (62.5) 256 (30.0) 1.16–1.84
Missing 19 8
Reason for admission Infectious disease 900 (66.0) 330 (36.6) < 0.001
∗∗
1.60 0.000
∗∗
Noninfection 442 (32.4) 116 (26.2) 1.25–2.06
Missing 21 8
Surgery since admission Yes 262 (19.2) 89 (34) 0.54 1.03 NA
No 1098 (80.6) 365 (33.2) 0.92–1.11
Missing 3
CI= conﬁdence interval, HAI=hospital-acquired infection, NA=not available.
∗,∗∗ separates the explanation of abbreviations.
Table 1
Prevalence of HAI in the different hospitals and wards.
Hospital H1 Total H1 H2 H3 Total
Ward NICU MICU SICU PICU AICU PICU
HAI No 258 227 190 675 95 17 121 908
Unknown 1 0 0 1 0 0 0 1
Yes 150 102 82 334 96 3 21 454
Total 409 329 272 1010 191 20 142 1363
% HAI 36.7% 31.0% 30.1% 33.1% 50.3% 15.0% 14.8% 33.3%
AICU= acute ICU, H=hospital, HAI=hospital-acquired infection, ICU= intensive care unit, MICU=medical ICU, NICU=neonatal ICU, PICU=pediatric ICU, SICU= surgical ICU.
Ngai et al. Medicine (2016) 95:27 www.md-journal.com
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signiﬁcantly related to a decreased risk forHAI (OR 0.38; 95%CI
0.19–0.75).
HAI diagnosis and culture results can be seen in Table 3.
Pneumonia was the most common HAI with 296 cases (65.2%)
diagnosed. Blood stream infection was the 2nd most common
cause of HAI with 96 cases (21.1%), with 46 (9.1%) in neonates
(Table 3). Among cases with reported HAI 269/454 (59.2%)
where intubated, whereas among the cases without HAI 346/909
(38.1%) were intubated (P<0.001). Among the 296 cases
diagnosed with hospital-acquired pneumonia (HAP) 208 were
intubated (70.1%).
Out of the 454 cases with HAI, 212 (46.9%) had positive
culture results with 276 isolates (1.3 isolates per survey). Most
common isolated species were: Klebsiella pneumoniae, Pseudo-
monas spp, Acinetobacter spp, and Staphylococcus aureus
(Tables 3 and 4). Resistance patterns were known in 171
instances. Culture conﬁrmed carbapenem resistant (CarbR)
strains were reported in 87 cases with carbapenem resistance
detected in 55% (23/42) of K pneumoniae isolates, 69% (25/36)
P aeruginosa, and in 67% (24/36) of A baumannii isolates.
K pneumoniae was the most common pathogen isolated from
patients with HAI, 58 strains out of 276 cultures with deﬁned
pathogen (21%). Of these 42 were from patients diagnosed with
pneumonia (72%), 50 had resistance data and out of those 23
were carbapenem resistant (46%). In the neonatal ICU 30% of
the isolated strains were K pneumoniae and of these, where
resistance data were available, 82% were carbapenem resistant.
Of all 95 Enterobacteriaceae organisms (including Escherichia
coli, Klebsiella spp, Enterobacter spp, Proteus spp, Citrobacter
spp, Serratia spp, andMorganella spp) 88% showed resistance to
3rd-generation cephalosporins, 40% showed resistance to both
cephalosporins and carbapenems. Resistance to 3rd-generation
cephalosporins was found in 56% of the K pneumoniae isolates
and 46% were resistant to both cephalosporins and carbape-
nems. Among Pseudomonas isolates 56% were carbapenem
resistant and A baumannii isolates 64%.
Of gram-positive bacteria S aureuswas the most common with
18 isolates, methicillin-resistant Staphylococcus aureus (MRSA)
accounting for 81% (13 out of 16, 2 isolates were lacking
resistance data).
Table 3
HAI case deﬁnitions, microorganisms, and resistance.
Micro-organism
Diagnosis n (number) Resistance n (%)
PNEU SEP SSI NEC CPI STI UTI OTH TOT RD Ceph R Carba R
Klebsiella pneumoniae/sp 34 14 0 0 1 0 0 1 50 42 38 (90%) 23 (55%)
Pseudomonas aeruginosa 38 5 2 0 0 0 0 1 46 36 NA 24 (71%)
Acinetobacter baumannii/sp 34 4 0 0 0 0 0 0 38 36 NA 24 (67%)
Candida sp 1 24 0 0 1 0 1 1 28 NA NA NA
Staphylococcus aureus 12 5 2 0 0 1 0 0 20 15 MRSA 13 (87%)
Escherichia coli 11 2 0 0 0 1 1 0 15 12 12 (100%) 5 (42%)
Staphylococcus sp 3 5 2 0 0 0 0 0 12 12 9 (75%) 1 (8%)
Enterobacter sp 7 4 0 0 0 0 0 0 11 11 8 (73%) 6 (55%)
Serratia sp 2 7 0 0 0 0 0 0 9 6 5 (83%) 0
Burkholderia cepacia 1 6 0 0 0 0 0 0 7 7 5 (71%) 3 (43%)
Stenotrophomonas maltophilia 5 1 0 0 1 0 0 0 7 7 1 (11%) 0
Providencia sp 5 0 0 0 0 0 0 0 5 5 4 (80%) 0
Enterococcus faecium 1 2 0 0 0 0 0 0 3 3 1 (33%) 1 (33%)
Proteus mirabilis sp 2 1 0 0 0 0 0 0 3 3 3 (100%) 2 (67%)
Achromobacter sp 2 0 0 0 0 0 0 0 2 2
Citrobacter sp 0 0 2 0 0 0 0 0 2 2 0 0
Haemophilus inﬂuenzae 1 0 0 0 1 0 0 0 2 3
Helicobacter pylori 2 0 0 0 0 0 0 0 2 2 2 (100%) 0
Shigella sp 1 0 1 0 0 0 0 0 2 2 2 (100%) 1 (50%)
Enterobacteriaceae not speciﬁed 1 0 0 0 0 0 0 0 1 1 1(100%) 1 (100%)
Fungi other 1 0 0 0 0 0 0 0 1 1
No growth 126 41 0 9 2 0 0 0 178
Total 296 120 9 9 6 2 2 3 454 249 91 (35%) 92 (40%)
Ceph R= cephalosporin resistant, CPI=CVC/PVC related infection, CR= carbapaenem resistant, HAI=hospital-acquired infection, MRSA=methicillin-resistant Staphylococcus aureus, NA=not available,
OTH= other, PNEU=pneuminia, RD= resistance data, SEP= sepsis, SSI= surgical site infection, STI= soft tissue infection, TOT= total, UTI=urinary tract infection.
Table 4
The most common HAI isolates and resistance per hospital including neonatal unit (neo).
Strains Klebsiella spp Pseudemonas spp Acinetobacter spp S Aeurus Other
Hospital N N (%) CR (%) N (%) CR N (%) N (%) CR N (%) N (%) MRSA (%) N %
H1
∗
126 23a (18%) 14 (70%) 31b (25%) 15 (71%) 20c (16%) 10 (55%) 13d (10%) 9 (82%) 39 31%
H1 Neo 53 16e (30%) 9 (82%) 4 (8%) 3 (75%) 0 0 4 (8%) 4 (100%) 29 55%
H2 49 9 (18%) 0 6 (12%) 2 (40%) 12 (24%) 9 (75%) 0 0 20 41%
H3 34 2 (6%) 0 5 (15%) 5 (100%) 6 (18%) 5 (83%) 0 0 21 62%
Total 262 50 (19%) 23 (55%) 46 (18%) 25 (69%) 38 (15%) 24 (67%) 18 (7%) 13 (81%) 109 42%
CR= carbapenem resistant, HAI=hospital-acquired infection, ICU= intensive care unit, MRSA=methicillin-resistant Staphylococcus aureus.
∗
Excluding neonatal ICU. Number of specimen lacking resistance data: a3, b10, c2, d2, e5 (resistance rates based on samples with resistance data).
Ngai et al. Medicine (2016) 95:27 Medicine
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Antibiotics were given to 1194 children (87.6%), 1 antibiotic
was given to 354 (29.6%) children, 2 antibiotics to 522 (43.7%),
3 antibiotics to 137 (11.5%), and 4 antibiotics to 8 patients
(0.6%). In total 1910 courses of antibiotics were given, with an
average of 1.6 antibiotics per child. Of all antibiotics used, 43%
were administered to treat HAI (Table 5).
Colistin was given to 96 children in 2 hospitals (H1 and H3) of
these 48 (49%) had reported carbapenem resistant strains. Of the
87 children with carbapenem resistant isolates 43 (49%) were
treated with colistin. The most common antibiotics administered
in combination with colistin were: carbapenems (n=36),
ﬂuoroquinolones (n=20), piperacillin-tazobactam (n=9), van-
comycin (n=7), and other (n=12). In H2 where no colistin was
used in children, there were 13 reported carbapenem resistant
strains (18% of isolated strains) and the most common treatment
for these cases was perﬂoxacine, either as monotherapy or as part
of a combination therapy.
4. Discussion
This study showed that one third of the surveyed children fulﬁlled
the criteria for HAI, with a high variation between types of ICUs.
The most common causes of HAI were hospital-acquired
pneumonia and septicemia including neonatal sepsis. About half
of the HAI cases were culture veriﬁed, commonly with gram-
negative bacteria resistant to cephalosporins and carbapenems.
MRSA was also commonly reported.
Comparing to the levels of HAI found in previous point
prevalence studies, as 9.4% in Iran[12] and between 21% and
28% in European ICUs,[9,13] the mean HAI prevalence of 31%
across these 3 Vietnamese pediatric ICUs is comparably high. The
prevalence of patients with HAI ranged widely between the ICUs:
from 14.8% to 50.3%. The wide range in HAI prevalence
between ICUs may be explained by differences in patient
population, severity of disease, proportion of referred patients
previously treated in other hospitals, intubation rates, and
infection control measures.
The signiﬁcant risk factors for HAI in uni- and multivariate
analysis were age <6 months, source of patients current hospital
(referral between departments), infection as reason for admis-
sion, and any comorbidity. The only invasive procedure showing
a signiﬁcant relation to increased risk for HAI was mechanical
ventilation (intubation). A recent report from the International
Nosocomial Infection Control Consortium (INICC) 2007 to
2012[2] from 503 ICUs shows that ventilator-associated
pneumonia is 15 times more common and catheter-associated
urinary tract infection 4 times more common in LMICs than in
HICs. This may be explained by inadequate resources or training
in infection control in LMIC. According to a study of the efﬁcacy
of nosocomial infection control (SENIC), up to a 3rd of HAI may
be preventable by appropriate infection control measures.[14]
This study shows an alarming rate of carbapenem resistance
among gram-negative bacteria. Of all Enterobacteriaceae the vast
majority was resistant to 3rd-generation cephalosporins and
40% were also carbapenem resistant. Carbapenem resistant
gram-negative bacteria are an urgent threat requiring immediate
action, since BSI in children caused by carbapenem resistant
Enterobacteriaceae has a high fatality rate.[15] Compared to other
studies, these are very high levels of resistance.[16,17] As multidrug
resistant (MDR) gram-negative pathogens are associated with a
3- to 4-fold increase in infection-related mortality,[18] these high
resistance rates are alarming. There might be some bias as mainly
severe patients not responding to treatment may have been
cultured.
In the COMPACT II study surveying resistance over several
Asia-Paciﬁc countries, the highest incidence of ESBL-producers
came from Vietnam, with 81% incidence among isolates from
ICU patients.[6] A lower incidence of 44%was found in non-ICU
patients, but our survey was carried out solely in ICU setting,
hence in an environment with the higher overall level of
resistance.
Due to high ESBL rates, carbapenems are often used
empirically, leading to further increased carbapenem resistance
rates in ICUs, likely through selection of resistant bacteria. Other
studies have also shown high levels of nosocomial infections with
carbapenem resistant A baumannii in Vietnam.[18,11] As
mentioned previously, rates of carbapenem resistant A bauman-
nii in our survey ranged up to 65% but were based only on few
isolates.
K pneumoniae was the most common pathogen isolated from
patients with HAI with 46% carbapenem resistance, in the
neonatal ICU 82%were carbapenem resistant. K pneumonia has
previously been reported as an infectious cause in Vietnamese
neonatal ICUs[19] as well as strains with carbapenem resis-
tance;[20] however, no prevalence has previously been reported.
The high rates of carbapenem resistant K pneumoniae in H1 is
Table 5
Speciﬁc antibiotics used for treatment. Antibiotics were given to
1194 children with an average of 1,6 antibiotics per child. Of all
antibiotics used, 43% were administered to treat HAI.
Antibiotic No HAI HAI TOT % For HAI
Meropenem 139 156 295 53%
Cefoperazone 240 45 285 16%
Imipenem and enzyme inhibitor 93 86 180
∗
48%
Metronidazole 116 52 168 31%
Vancomycin 84 77 161 48%
Ceftriaxone 98 11 109 10%
Colistin 7 89 96 93%
Levoﬂoxacin 42 52 94 55%
Ceftazidime 38 22 60 37%
Tobramycin 37 23 60 38%
Ciproﬂoxacin 15 37 52 71%
Piperacillin and enzyme inhibitor 21 24 45 53%
Cefotaxime 38 3 41 7%
Amikacin 24 9 33 27%
Peﬂoxacin 3 29 32 91%
Fluconazole 7 22 29 76%
Amphotericin B 1 24 26
∗
92%
Cefepime 11 13 24 54%
Fosfomycin 4 16 20 80%
Azithromycin 10 2 12 17%
Gentamicin 8 4 12 33%
Fosfomycin 4 6 10 60%
Ampicillin and enzyme inhibitor 4 4 8 50%
Cefuroxime 6 1 7 14%
Sulfamethoxazole and trimethoprim 1 6 7 86%
Clindamycin 1 3 4 75%
Sulbactam 3 1 4 25%
Ampicillin 3 0 3 0%
Moxiﬂoxacin 2 1 3 33%
Norﬂoxacin 3 0 3 0%
Oxacillin 2 1 3 33%
Other 16 8 24 33%
Total 1081 827 1910 43%
HAI=hospital-acquired infection, No HAI= antibiotics used for treatment of other diagnosis then HAI,
TOT= total.
∗
1 Unknown.
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suggestive of a clonal outbreak which is corroborated by
genotyping results showing most isolates harbored K pneumo-
niae carbapenemase 2 (unpublished data, on-going work). There
are no previous reports of K pneumoniae carbapenemase 2 in
Vietnam, however from neighboring China.[21] New Delhi
metallo-beta-lactamase 1 (NDM-1) has previously been reported
in Vietnamese patients and in the environment.[20,22]
There was a big variation in what antimicrobials or
combinations of antimicrobials that were used to treat HAI
caused by carbapenem resistant Enterobacteriaceae. Colistin was
used in 49% of the cases with culture conﬁrmed carbapenem
resistant strains – either as monotherapy or in combination.
Carbapenem was used alone or in combination in half of the
cases. In the cases with diagnosed carbapenem resistant Enter-
obacteriaceae, the variety of treatments given in the survey
highlights a very important point; despite being a dominating
etiology of HAI, there are no clear treatment guidelines available
in Vietnam to treat carbapenem resistant Enterobacteriaceae. A
meta-analysis based on 20 studies concluded that for critically ill
patients with severe infections due to carbapenemase-producing
Enterobacteriaceae combination antibiotic treatment may offer a
comparative advantage over monotherapy with regard to the
mortality.[23] It is concerning that colistin was used in half of
patients without culture conﬁrmed carbapenem resistance.
However, in case of poor response to given treatment, there
may be good reasons to suspect that the etiology is carbapenem
resistant strains. Increased use of colistin will induce selective
pressure for colistin-resistance isolates to emerge, which has been
documented in Asia.[24]
This study highlights the importance of functioning infection
control including hand hygiene, antibiotic stewardship, and good
laboratory capability.[25] Change in antibiotic policy, for example,
substitution of piperacillin/tazobactam for extended-spectrum
cephalosporins in community acquired infections, has shown to be
successful in decreasing the prevalence of ESBL producing K
pneumoniae and E coli,[26] and could be considered as treatment
option. Evidence-based actions to improve antibiotic use and
prevent further selection of carbapenem and colistin resistance are
urgently needed. The effect of the actions should be continuously
monitored, and standard treatment guidelines should regularly be
updated at national, regional, and local levels.[27]
4.1. Limitations of the study
This is a PPS presenting cross-sectional study data. In order to
assess treatment outcome in relation to resistance a longitudinal
design would be required. Comparing neonatal wards with
general pediatric wards may not be entirely appropriate as there
is a variation between age groups and type of HAI – for example
BSI or surgical site infection may be more likely in neonates
whereas UTI may be more common in children over 5 years age,
as shown in this study K pneumoniae infections were more
common in neonates, also shown in earlier studies.[28] Patients
were entered at 0 months of age regardless if they were pre- or
full-term, and considering that the included Neonatal Intensive
Care Units is a large tertiary referral center, the patients were
mostly preterm. Perinatal risk factors such mode of delivery,
gestational age, birth weight, asphyxia, respiratory distress
syndrome, or congenital malformations were not obtained but
have a relevance for susceptibility to HAI. There may be an
overrepresentation of severe cases, as increased length of stay
means increased chance of being in a survey. There are also
difﬁculties interpreting the microbiology given that much was
from cultured of nonsterile sites (e.g., tracheal aspirate) and may
represent colonization. Antibiotic sensitivity data were not
available for all cultures which might induce a bias. There is
also a difﬁculty on assessing “appropriateness of therapy” when
no longitudinal data are collected.
In order to design appropriate interventions, there is a need to
assess the pediatric HAI and antibiotic resistance situation[28]
using longitudinal study designs and assessing the burden of
resistance including additional morbidity, treatment time, and
costs as well as comparing patients with carbapenem resistance
and those with susceptible strains. Also there is a need to assess
the most effective treatment for carbapenem resistant infections
in children and neonates including PK/PD studies as dosing in
children is often based on limited data and may lead to under-
dosing with risk of increasing resistance, or overdosing with risk
for adverse drug reactions.[29] Interventions to decrease the
incidence of HAI is urgent and should however not be delayed but
implemented continuously.[24,25]
5. Conclusion
This PPS in 3 pediatric ICUs found a high prevalence of HAI. The
microbiological results showed that most of the positive cultures
where gram-negative bacteria with high levels of carbapenem-
resistance in K pneumoniae isolates. There was common use of
broad spectrum antibiotics as cephalosporins and carbapenems,
and the last resort antibiotic colistin was one of the most
frequently used. The high levels of resistance and common use of
broad-spectrum antibiotics suggest that interventions are needed
to prevent HAI and to rationalize antibiotic use.
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